| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 105 | 1.791 | 17.997 | 0 | - | - | - | - |
| Total Income - EUR | - | - | 105 | 1.792 | 19.963 | 0 | - | - | - | - |
| Total Expenses - EUR | - | - | 96 | 1.547 | 23.804 | 124 | - | - | - | - |
| Gross Profit/Loss - EUR | - | - | 9 | 245 | -3.841 | -124 | - | - | - | - |
| Net Profit/Loss - EUR | - | - | 6 | 191 | -4.021 | -124 | - | - | - | - |
| Employees | - | - | 0 | 0 | 1 | 0 | - | - | - | - |
Check the financial reports for the company - Voconcept Bio Tech Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 0 | 0 | 0 | 0 | - | - | - | - |
| Current Assets | - | - | 872 | 565 | 507 | 497 | - | - | - | - |
| Inventories | - | - | 729 | 461 | 452 | 443 | - | - | - | - |
| Receivables | - | - | 0 | 0 | 0 | 0 | - | - | - | - |
| Cash | - | - | 144 | 104 | 55 | 54 | - | - | - | - |
| Shareholders Funds | - | - | 225 | 412 | -3.617 | -3.672 | - | - | - | - |
| Social Capital | - | - | 219 | 215 | 211 | 207 | - | - | - | - |
| Debts | - | - | 647 | 152 | 4.123 | 4.169 | - | - | - | - |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | - | - | - | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4645 - 4645" | |||||||||
| CAEN Financial Year |
4645
|
|||||||||
Comments - Voconcept Bio Tech Srl